Bleichroeder LP Gritstone Bio, Inc. Transaction History

Bleichroeder LP

  • $296 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021
SELL
$2.57 - $4.22 $434,430 - $713,344
-169,039 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$5.69 - $8.17 $956,232 - $1.37 Million
168,055 Added 17078.76%
169,039 $1.12 Million
Q1 2020

May 14, 2020
SELL
$5.47 - $11.3 $919,260 - $1.9 Million
-168,055 Reduced 99.42%
984 $5,000
Q1 2020

May 14, 2020
BUY
$5.47 - $11.3 $924,643 - $1.91 Million
169,039 New
169,039 $984,000

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email